Hims & Hers review: what it prescribes, what it costs, who it suits
FDA-approved (after a 2026 pivot). A publicly-traded platform that has moved decisively to FDA-approved medicine and is one of the few offering the oral Wegovy pill cheaply. The trade-off is the thinnest clinical touch here: async-only, no labs — fine for a straightforward start, less so if your history is complicated.
- What it prescribes
- Now centered on branded, FDA-approved semaglutide — injectable Wegovy (including the higher-dose 7.2 mg), the oral Wegovy pill, and Ozempic. Hims received one of the FDA's 2025 warning letters over compounded-GLP-1 marketing, then settled with Novo Nordisk in March 2026 and moved new patients to branded products, saying it will no longer advertise compounded GLP-1s and will keep them only for the limited set of patients whose clinical needs a commercial product cannot meet.
- How the consult works
- Asynchronous only — a provider reviews your intake and replies by message, usually within a day. No video visits, and no lab work is ordered or required.
- Insurance
- Now bills commercial insurance for the branded drugs (new since the branded pivot) and integrates the Novo Nordisk savings card; a covered patient can reach a very low copay.
- What it costs
- A weight-loss membership (about $39 the first month, then roughly $149/mo) with the drug separate — oral Wegovy from about $149/mo and injectable Wegovy around $299/mo self-pay. As of mid-2026 — verify current.
What to watch with Hims & Hers
Async-only means no clinician actually sees or examines you — you are responsible for flagging your full history in the intake.
Go to Hims & Hers
Visit Hims & HersWe earn nothing from this link. We have no commercial relationship with Hims & Hers, and the link is here because the page would be less useful without it.
Frequently asked questions
Does Hims & Hers prescribe FDA-approved GLP-1s or compounded copies?
FDA-approved (after a 2026 pivot). Now centered on branded, FDA-approved semaglutide — injectable Wegovy (including the higher-dose 7.2 mg), the oral Wegovy pill, and Ozempic. Hims received one of the FDA's 2025 warning letters over compounded-GLP-1 marketing, then settled with Novo Nordisk in March 2026 and moved new patients to branded products, saying it will no longer advertise compounded GLP-1s and will keep them only for the limited set of patients whose clinical needs a commercial product cannot meet.
How does a Hims & Hers consultation work?
Asynchronous only — a provider reviews your intake and replies by message, usually within a day. No video visits, and no lab work is ordered or required.
Does Hims & Hers take insurance?
Now bills commercial insurance for the branded drugs (new since the branded pivot) and integrates the Novo Nordisk savings card; a covered patient can reach a very low copay.
What does Hims & Hers cost?
A weight-loss membership (about $39 the first month, then roughly $149/mo) with the drug separate — oral Wegovy from about $149/mo and injectable Wegovy around $299/mo self-pay. As of mid-2026 — verify current. Prices in this market move quickly — treat this as the shape of the bill, not a quote.
Is a compounded GLP-1 from any service the same as the branded drug?
No. A compounded product is not FDA-approved: the agency has not reviewed that specific product for identity, potency, purity or sterility. The shortages that made routine compounding lawful ended — tirzepatide October 2, 2024, semaglutide February 21, 2025 — and in 2026 the FDA has been issuing warning letters to telehealth companies over how compounded GLP-1s are marketed. That is the single fact that reorders this market, and it applies whichever service you pick.
Compare with the others
Sources: Hims — Weight Loss ↗ · Hims & Hers — Strategic shift to FDA-approved GLP-1s / Novo Nordisk collaboration (Mar 9, 2026) ↗ · FDA — Warning letter, Hims & Hers Health, Inc. dba Hers (Sep 9, 2025) ↗
We rate medicines, not companies, and we do not give a telehealth service a score — our ratings are built on FDA recall data about drugs, and no equivalent data exists about a business. Prices and programme terms in this market change quickly; verify the current terms on the service’s own site before paying. Not medical advice.